Positive APOLLO trial topline results demonstrated statistically significant and clinically meaningful benefit across all study ...

Disc Medicine plans to resubmit its blood-disorder drug for FDA approval by year-end after a late-stage trial met all its ...

Spending money on PC cleanup apps? Discover how Windows' built-in tools safely automate system maintenance, clean junk, and ...

All three fibroblast-treated groups had higher disc heights than vehicle controls, measured by normalized percent disc height ...

Protect your personal files from theft with data encryption. Secure system drives, external USBs, and cloud storage using ...

After a medical emergency, Eylsia Nicolas pauses vocal recording, launches HHGC Studios for AI transparency, and continues ...

There’s something distinctly unsettling about watching your cat’s skin ripple and roll along its spine, seemingly on its own.

As part of the collaboration, Updation will leverage U.S. Bank Embedded Payment Solutions, including a for-benefit-of (FBO) account structure. The structure allows funds to be securely held and moved ...

The 2025 workforce at Ubisoft Dusseldorf were straight-up cuts. This time, Ubisoft is hoping the reductions at its trio of ...

Disc Medicine's stock surged 32% premarket ahead of Phase 3 APOLLO trial results for bitopertin, an EPP treatment.

Rollins (ROL) rated Buy with $57 target: contrarian upside after misses. 75% recurring revenue, secular tailwinds; key risks flagged. Click here to read.

Restomods, engine swaps, suspension upgrades and aftermarket wheels can make a classic more usable or less valuable. Here is ...